Biotech · Private company
Acerus Pharmaceuticals Corporation
Track this companyFree. Adds Acerus Pharmaceuticals Corporation to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- High dose testosterone nasal gel, single dosePhase 1 · Female Sexual DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- Low dose testosterone nasal gel, single dosePhase 1 · Female Sexual DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- Medium dose testosterone nasal gel, multiple dosePhase 1 · Female Sexual DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- Medium dose testosterone nasal gel, single dosePhase 1 · Female Sexual DysfunctionClinicalTrials.gov · fetched Nov 12, 2026
- NatestoHypogonadismClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Natesto Testosterone Nasal Gel for Hypogonadal MenPHASE4 · WITHDRAWN · started Jan 1, 2023ClinicalTrials.gov NCT05484167 · fetched Nov 12, 2026
- A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone GelPHASE4 · UNKNOWN · started Jul 1, 2021ClinicalTrials.gov NCT04976595 · fetched Nov 12, 2026
- A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone InjectionsPHASE4 · COMPLETED · started Aug 7, 2020ClinicalTrials.gov NCT04439799 · fetched Nov 12, 2026
- A Study to Evaluate the Effect of Testosterone Replacement Therapy (TRT) on the Incidence of Major Adverse Cardiovascular Events (MACE) and Efficacy Measures in Hypogonadal MenPHASE4 · COMPLETED · started May 3, 2018ClinicalTrials.gov NCT03518034 · fetched Nov 12, 2026
- PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal WomenPHASE1 · COMPLETED · started Sep 1, 2011ClinicalTrials.gov NCT01364623 · fetched Nov 12, 2026